Logo image of TACT

TRANSACT TECHNOLOGIES INC (TACT) Stock Fundamental Analysis

USA - NASDAQ:TACT - US8929181035 - Common Stock

4.65 USD
+0.02 (+0.43%)
Last: 10/23/2025, 8:00:01 PM
4.76 USD
+0.11 (+2.37%)
After Hours: 10/16/2025, 8:16:58 PM
Fundamental Rating

4

Overall TACT gets a fundamental rating of 4 out of 10. We evaluated TACT against 34 industry peers in the Technology Hardware, Storage & Peripherals industry. While TACT has a great health rating, there are worries on its profitability. TACT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TACT had negative earnings in the past year.
TACT had a positive operating cash flow in the past year.
TACT had negative earnings in 4 of the past 5 years.
In multiple years TACT reported negative operating cash flow during the last 5 years.
TACT Yearly Net Income VS EBIT VS OCF VS FCFTACT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

TACT has a Return On Assets of -19.38%. This is in the lower half of the industry: TACT underperforms 67.65% of its industry peers.
With a Return On Equity value of -27.59%, TACT perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -19.38%
ROE -27.59%
ROIC N/A
ROA(3y)-8.37%
ROA(5y)-9.27%
ROE(3y)-12.56%
ROE(5y)-13.34%
ROIC(3y)N/A
ROIC(5y)N/A
TACT Yearly ROA, ROE, ROICTACT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

With an excellent Gross Margin value of 47.47%, TACT belongs to the best of the industry, outperforming 85.29% of the companies in the same industry.
In the last couple of years the Gross Margin of TACT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for TACT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.24%
GM growth 5Y0.64%
TACT Yearly Profit, Operating, Gross MarginsTACT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

7

2. Health

2.1 Basic Checks

TACT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TACT has more shares outstanding
Compared to 5 years ago, TACT has more shares outstanding
TACT has a worse debt/assets ratio than last year.
TACT Yearly Shares OutstandingTACT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
TACT Yearly Total Debt VS Total AssetsTACT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

TACT has an Altman-Z score of 3.89. This indicates that TACT is financially healthy and has little risk of bankruptcy at the moment.
TACT has a Altman-Z score of 3.89. This is in the better half of the industry: TACT outperforms 70.59% of its industry peers.
The Debt to FCF ratio of TACT is 0.50, which is an excellent value as it means it would take TACT, only 0.50 years of fcf income to pay off all of its debts.
TACT has a better Debt to FCF ratio (0.50) than 91.18% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that TACT is not too dependend on debt financing.
TACT's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. TACT outperforms 67.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.5
Altman-Z 3.89
ROIC/WACCN/A
WACC8.6%
TACT Yearly LT Debt VS Equity VS FCFTACT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 3.08 indicates that TACT has no problem at all paying its short term obligations.
The Current ratio of TACT (3.08) is better than 79.41% of its industry peers.
A Quick Ratio of 2.07 indicates that TACT has no problem at all paying its short term obligations.
TACT has a Quick ratio of 2.07. This is in the better half of the industry: TACT outperforms 79.41% of its industry peers.
Industry RankSector Rank
Current Ratio 3.08
Quick Ratio 2.07
TACT Yearly Current Assets VS Current LiabilitesTACT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for TACT have decreased strongly by -160.00% in the last year.
The Revenue has decreased by -9.09% in the past year.
The Revenue has been decreasing by -1.06% on average over the past years.
EPS 1Y (TTM)-160%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)-9.09%
Revenue growth 3Y3.27%
Revenue growth 5Y-1.06%
Sales Q2Q%18.96%

3.2 Future

TACT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.94% yearly.
The Revenue is expected to grow by 13.13% on average over the next years. This is quite good.
EPS Next Y38.8%
EPS Next 2Y30.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.91%
Revenue Next 2Y13.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TACT Yearly Revenue VS EstimatesTACT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
TACT Yearly EPS VS EstimatesTACT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

TACT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TACT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TACT Price Earnings VS Forward Price EarningsTACT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, TACT is valued cheaper than 88.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.77
EV/EBITDA N/A
TACT Per share dataTACT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

TACT's earnings are expected to grow with 30.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.94%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TACT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRANSACT TECHNOLOGIES INC

NASDAQ:TACT (10/23/2025, 8:00:01 PM)

After market: 4.76 +0.11 (+2.37%)

4.65

+0.02 (+0.43%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners52.85%
Inst Owner Change0.85%
Ins Owners4.92%
Ins Owner Change1.31%
Market Cap46.92M
Revenue(TTM)47.95M
Net Income(TTM)-8632000
Analysts82.86
Price Target5.1 (9.68%)
Short Float %0.03%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.2%
Min EPS beat(2)80.39%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)61.24%
Min EPS beat(4)26.47%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)176.94%
EPS beat(12)12
Avg EPS beat(12)263.61%
EPS beat(16)15
Avg EPS beat(16)196.58%
Revenue beat(2)2
Avg Revenue beat(2)11.86%
Min Revenue beat(2)7.79%
Max Revenue beat(2)15.92%
Revenue beat(4)2
Avg Revenue beat(4)2.14%
Min Revenue beat(4)-11.88%
Max Revenue beat(4)15.92%
Revenue beat(8)4
Avg Revenue beat(8)1.16%
Revenue beat(12)8
Avg Revenue beat(12)5.84%
Revenue beat(16)11
Avg Revenue beat(16)5.73%
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)60%
EPS NY rev (1m)0%
EPS NY rev (3m)21.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.98
P/FCF 7.77
P/OCF 7.63
P/B 1.5
P/tB 1.64
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.6
FCFY12.88%
OCF(TTM)0.61
OCFY13.11%
SpS4.75
BVpS3.1
TBVpS2.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.38%
ROE -27.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.47%
FCFM 12.6%
ROA(3y)-8.37%
ROA(5y)-9.27%
ROE(3y)-12.56%
ROE(5y)-13.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.24%
GM growth 5Y0.64%
F-Score4
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.5
Debt/EBITDA N/A
Cap/Depr 14.5%
Cap/Sales 0.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.08
Quick Ratio 2.07
Altman-Z 3.89
F-Score4
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)63.1%
Cap/Depr(5y)77.66%
Cap/Sales(3y)1.41%
Cap/Sales(5y)2.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-160%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y38.8%
EPS Next 2Y30.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.09%
Revenue growth 3Y3.27%
Revenue growth 5Y-1.06%
Sales Q2Q%18.96%
Revenue Next Year18.91%
Revenue Next 2Y13.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year110.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.59%
FCF growth 3YN/A
FCF growth 5Y-15.06%
OCF growth 1Y1.47%
OCF growth 3YN/A
OCF growth 5Y-17.43%